Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 39, 1437-1442, May 1, 1979]
© 1979 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Becker, F. F.
Right arrow Articles by Sell, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Becker, F. F.
Right arrow Articles by Sell, S.

Differences in Serum {alpha}-Fetoprotein Concentrations during the Carcinogenic Sequences Resulting from Exposure to Diethylnitrosamine or Acetylaminofluorene1

Frederick F. Becker2 and Stewart Sell

Department of Anatomic and Research Pathology, M. D. Anderson Hospital and Tumor Institute, Houston, Texas 77030 [F. F. B.], and Department of Pathology, The University of California School of Medicine, San Diego, California 92037 [S. S.]

Serum {alpha}-fetoprotein (AFP) concentrations were determined by a sensitive radioimmunoassay throughout various carcinogenic regimens at several concentrations of N-2-acetylaminofluorene (AAF) and diethylnitrosamine (DEN). A number of results derived from these experiments demonstrated striking differences between the effects of these hepatocarcinogens. The almost immediate elevation of AFP resulting from exposure to AAF at all levels tested was absent with DEN; AFP elevation occurred only after a significant number of weeks of DEN exposure. This and other findings suggest that neither hepatocyte injury alone nor selected hepatocyte gene derepression, as related to carcinogenicity, is responsible for the early AFP elevation with AAF and other carcinogens. We postulate, rather, that AAF stimulates the production of AFP by a specific cell population, as has been suggested in the literature, which may or may not be related to carcinogenesis.

The rise of AFP, when it did occur after DEN exposure, was rapid and progressive and appeared to be associated with the presence of histologically malignant cell foci. DEN exposure resulted in a much earlier appearance of hepatocellular carcinomas than with AAF. These were almost invariably multiple and associated with microscopic foci of malignancy, neither finding being demonstrated with AAF. The DEN-induced carcinomas invariably produced AFP while many which resulted from AAF exposure did not. Therefore, since every rat exposed to a carcinogenic regimen of AAF demonstrated a remarkably similar kinetic of AFP response, the pattern for a given rat was not predictive of the functional activity of the carcinomas which resulted.

1 These experiments were supported by Grant CA-20657 and Contract VO-1-CP-33403 awarded by the National Cancer Institute, Department of Health, Education, and Welfare.

2 To whom requests for reprints should be addressed.

Received 2/ 6/78. Accepted 1/23/79.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1979 by the American Association for Cancer Research.